Kensington Investment Counsel, LLC Bristol Myers Squibb CO Transaction History

Kensington Investment Counsel, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $133,384 - $151,232	2,780 Added 12.95%	24,248 $1.31 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $178,842 - $213,408	-3,689 Reduced 14.66%	21,468 $1.1 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $85,677 - $95,800	1,480 Added 6.25%	25,157 $1.46 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $174,501 - $193,756	2,739 Added 13.08%	23,677 $1.51 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $304,828 - $345,744	4,639 Added 28.46%	20,938 $1.45 Million
Q4 2022 Feb 15, 2023	SELL	$68.48 - $81.09 $6,300 - $7,460	-92 Reduced 0.56%	16,299 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $99 - $58,782	765 Added 4.9%	16,391 $1.17 Million
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $19,752 - $21,754	-272 Reduced 1.71%	15,626 $1.2 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $977,409 - $1.17 Million	15,898 New	15,898 $1.16 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.02 Million - $1.22 Million	-16,529 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $89,293 - $104,095	1,665 Added 11.2%	16,529 $1.03 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $28,478 - $31,013	460 Added 3.19%	14,864 $993,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $70,377 - $79,153	1,186 Added 8.97%	14,404 $909,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $763,207 - $864,853	13,218 New	13,218 $820,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Kensington Investment Counsel, LLC with notifications on news.